Research and Markets: Progenitor and Stem Cell Technologies and Therapies Reviews the Range Of Progenitor and Stem …

By Dr. Matthew Watson

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/2fee68d4/progenitor_and_ste) has announced the addition of Woodhead Publishing Ltd's new book "Progenitor and Stem Cell Technologies and Therapies" to their offering.

Progenitor and stem cell technologies and therapies

Progenitor and stem cells have the ability to renew themselves and change into a variety of specialised types, making them ideal materials for therapy and regenerative medicine. "Progenitor and stem cell technologies and therapies" reviews the range of progenitor and stem cells available and their therapeutic application.

Part one reviews basic principles for the culture of stem cells before discussing technologies for particular cell types. These include human embryonic, induced pluripotent, amniotic and placental, cord and multipotent stem cells. Part two discusses wider issues such as intellectual property, regulation and commercialisation of stem cell technologies and therapies. The final part of the book considers the therapeutic use of stem and progenitor cells. Chapters review the use of adipose tissue-derived stem cells, umbilical cord blood (UCB) stem cells, bone marrow, auditory and oral cavity stem cells. Other chapters cover the use of stem cells in therapies in various clinical areas, including lung, cartilage, urologic, nerve and cardiac repair.

With its distinguished editor and international team of contributors, "Progenitor and stem cell technologies and therapies" is a standard reference for both those researching in cell and tissue biology and engineering as well as medical practitioners investigating the therapeutic use of this important technology.

Key Features:

- Reviews the range of progenitor and stem cells available and outlines their therapeutic application

- Examines the basic principles for the culture of stem cells before discussing technologies for particular cell types, including human embryonic, induced pluripotent, amniotic and placental, cord and multipotent stem cells

- Includes a discussion of wider issues such as intellectual property, regulation and commercialisation of stem cell technologies and therapies

For more information visit http://www.researchandmarkets.com/research/2fee68d4/progenitor_and_ste

Continued here:
Research and Markets: Progenitor and Stem Cell Technologies and Therapies Reviews the Range Of Progenitor and Stem ...

Related Post


categoriaCardiac Stem Cells commentoComments Off on Research and Markets: Progenitor and Stem Cell Technologies and Therapies Reviews the Range Of Progenitor and Stem … | dataMarch 22nd, 2012

About...

This author published 5852 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024